Mangalam Drugs and Organics share news and announcements
NSE: MANGALAMBSE: 532637Pharmaceuticals & BiotechnologySmall Cap
Last close ₹28.65down ₹0.92 (3.11%)BSE ₹28.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹29.57.
52-week range of traded prices to 23 Oct 2026
₹22.80Low, 29 Dec 2025₹71.99High, 23 Oct 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹45 Cr3,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 May 2026
- 0.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- −30.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −12.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 May 2026
- 1.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 19,55176.4% delivered
Mangalam Drugs and Organics share news and announcements
527 announcements, routine notices left out, newest first. Page 10 of 11.
Nov 2013
5 Nov · Board meeting
Inter-alia to consider and take on record Unaudited Financial results for the Quater ended September 30,2013
Oct 2013
Sep 2013
2 Sep · Corporate action
Company has fixed the Book Closure period from September 19, 2013 to September 26, 2013 for the purpose of Annual General Meeting.
Aug 2013
5 Aug · Board meeting
Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2013.
May 2013
10 May · Board meeting
To consider and approve the audited financial results for the year ended March 31, 2013.
Feb 2013
1 Feb · Board meeting
Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended December 31, 2012.
Jan 2013
Dec 2012
Nov 2012
1 Nov · Board meeting
Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended September 30, 2012.
Oct 2012
Aug 2012
29 Aug · Corporate action
Company has fixed the Book Closure period from September 20, 2012 to September 27, 2012 for the purpose of Annual General Meeting.6 Aug · Board meeting
Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2012.
Jul 2012
17 Jul · Board meeting
Inter-alia to consider and approve the audited financial results for the year ended March 31, 2012 and to recommend dividend, if any
May 2012
11 May · Board meeting
Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended March 31, 2012.
Feb 2012
2 Feb · Board meeting
Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended December 31, 2011.
Dec 2011
Sep 2011
13 Sep · Meeting
Annual General Meeting of the Company will be held on September 29, 2011.8 Sep · Corporate action
Company has fixed the Book Closure period from September 22, 2011 to September 29, 2011 for the purpose of Annual General Meeting.
Aug 2011
3 Aug · Board meeting
Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2011.
Jun 2011
May 2011
14 May · Board meeting
Inter alia, to consider and approve the Audited Financial Results for the year ended March 31, 2011 and to recommend dividend, if any.
Feb 2011
2 Feb · Board meeting
Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended December 31, 2010.
Jan 2011
Dec 2010
Nov 2010
Oct 2010
29 Oct · Board meeting
Company had informed the Exchange regarding the meeting of the Board of Directors of the Company was scheduled to be held on October 30, 2010 Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended September 30, 2010. The Company has now informed the Exchange that the aforesaid board meeting has been postponed to November 12, 2010.Not held on this date
18 Oct · Board meeting
Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended September 30, 2010.
Sep 2010
7 Sep · Meeting
Annual General Meeting of the Company will be held on September 30, 2010.
Aug 2010
24 Aug · Corporate action
Company has fixed the Book Closure period from September 23, 2010 to September 30, 2010 for the purpose of Annual General Meeting.
Jul 2010
15 Jul · Board meeting
Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2010.
May 2010
29 May · Management
At the meeting of the Board of Directors of the Company held on May 29, 2010, Mr. Mukul Ajaykumar Sukhani has resigned as Director of the Company with effect from May 29, 2010.21 May · Board meeting
Inter alia, to consider and take on record the audited financial results and accounts for the year ended on March 31, 2010.7 May · Results
The Company will publish the Audited Financial Results for the financial year ended March 31, 2010 on or before May 31, 2010 instead of publishing unaudited Financial Results for the quarter ended March 31, 2010.
Apr 2010
13 Apr · Disclosure
Disclosure of details of acquisition of Mangalam Drugs and Organic Limited (Target Company) and stock exchanges where the shares of the target Company are listed , in terms of regulations 7(1) and 7(1A). The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Apr · Disclosure
Disclosure pursuant to regulations 7(3) and 13(6) SEBI (Substantial Acquisition of Shares and takeovers) Regualtions, 1997. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Apr · Disclosure
Disclosure under Regulation 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
14 Jan · Board meeting
Meeting on 28 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”